Aller au contenu principal
Profil bibliographique

Shiri Zakin

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

8Publications signalées
605Citations signalées
0Affiliations récentes

Les domaines associés

Antifungal resistance and susceptibilityMitochondrial Function and PathologyFungal Infections and StudiesAlzheimer's disease research and treatmentsProbiotics and Fermented Foods

Les publications récentes

Accès ouvert 2026 article OpenAlex

Accelerating Leigh syndrome drug discovery through deep learning screening in brain organoids

Carmen Menacho, Satoshi Okawa, Iris Álvarez‐Merz, Annika Wittich et autres

Leigh syndrome (Leigh) is an untreatable mitochondrial disorder characterized by lactic acidosis and basal ganglia and midbrain pathology, leading to psychomotor regression and early death. We previously uncovered impaired neuronal morphogenesis in Leigh cerebral organoids carrying SURF1 gene variants. Leveraging this phenotype, …

de, us, lu, pl, es, it, gb (code pays fourni par la source)

5 citations Nature Communications
Accès ouvert 2026 other OpenAlex

Accelerating Leigh syndrome drug discovery through deep learning screening in brain organoids

Carmen Menacho, Satoshi Okawa, Iris Álvarez‐Merz, Annika Wittich et autres

Leigh syndrome (Leigh) is an untreatable mitochondrial disorder characterized by lactic acidosis and basal ganglia and midbrain pathology, leading to psychomotor regression and early death. We previously uncovered impaired neuronal morphogenesis in Leigh cerebral organoids carrying SURF1 gene variants. Leveraging this phenotype, …

0 citations Fraunhofer-Publica (Fraunhofer-Gesellschaft)
Accès ouvert 2024 preprint OpenAlex

Industrializing yeast as a drug repurposing platform for inherited metabolic diseases

Mathuravani A. Thevandavakkam, Natalie E. Long, Briannna M. Roel, Kristin A. Kantautas et autres

Summary The development of therapies for rare diseases, particularly inherited metabolic disorders (IMDs), faces significant challenges due to the high cost and lengthy timelines involved. This study presents a yeast-based platform for drug repurposing that capitalizes on the remarkable similarity between yeast …

1 citation bioRxiv (Cold Spring Harbor Laboratory)
Accès ouvert 2024 preprint OpenAlex

Deep learning-driven neuromorphogenesis screenings identify repurposable drugs for mitochondrial disease

Carmen Menacho, Satoshi Okawa, Iris Álvarez‐Merz, Annika Wittich et autres

Summary Mitochondrial disease encompasses untreatable conditions affecting tissues with high energy demands. A severe manifestation of mitochondrial disease is Leigh syndrome (Leigh), which causes defects in basal ganglia and midbrain regions, psychomotor regression, lactic acidosis, and early death. We previously generated isogenic …

de, us, lu, pl, es, gb (code pays fourni par la source)

9 citations bioRxiv (Cold Spring Harbor Laboratory)
Accès ouvert 2018 article OpenAlex

Antifungal tolerance is a subpopulation effect distinct from resistance and is associated with persistent candidemia

Alexander Jacob Rosenberg, Iuliana V. Ene, Maayan Bibi, Shiri Zakin et autres

Tolerance to antifungal drug concentrations above the minimal inhibitory concentration (MIC) is rarely quantified, and current clinical recommendations suggest it should be ignored. Here, we quantify antifungal tolerance in Candida albicans isolates as the fraction of growth above the MIC, and find …

il, us, br (code pays fourni par la source)

282 citations Nature Communications
Accès ouvert 2017 preprint OpenAlex

Clearing the FoG: Antifungal tolerance is a subpopulation effect that is distinct from resistance and is associated with persistent candidemia

Alexander Jacob Rosenberg, Iuliana V. Ene, Maayan Bibi, Shiri Zakin et autres

Abstract Drug susceptibility, defined by the minimal inhibitory concentration (MIC), often does not predict whether fungal infections will respond to therapy in the clinic. Tolerance at supra-MIC antifungal drug concentrations is rarely quantified and current clinical recommendations suggest it be ignored. Here, …

il, us, br (code pays fourni par la source)

2 citations bioRxiv (Cold Spring Harbor Laboratory)
Accès ouvert 2017 article OpenAlex

Multidrug-Resistant Candida haemulonii and C. auris , Tel Aviv, Israel

Ronen Ben‐Ami, Judith G. Berman, Ana Novikov, Edna Bash et autres

Candida auris and C. haemulonii are closely related, multidrug-resistant emerging fungal pathogens that are not readily distinguishable with phenotypic assays. We studied C. auris and C. haemulonii clinical isolates from 2 hospitals in central Israel. C. auris was isolated in 5 patients …

304 citations Emerging infectious diseases
Accès ouvert 2016 article OpenAlex

Candida haemulonii and Candida auris: Emerging Multidrug-Resistant Species With Distinct Virulence and Epidemiological Characteristics

Talya Finn, Anna Novikov, Shiri Zakin, Edna Bash et autres

Background. Candida haemulonii and Candida auris are recently described, closely related drug-resistant Candida species. Little is known about the pathogenicity and epidemiological characteristics of these species. Methods. We reviewed Candida clinical isolates recovered from January 2008 through December 2015 at the Tel …

il (code pays fourni par la source)

3 citations Open Forum Infectious Diseases

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.